Subject(s)
Acne Keloid , Acne Vulgaris , Folliculitis , Skin Diseases , Humans , Acne Keloid/complicationsSubject(s)
Alopecia Areata , Minoxidil , Alopecia/drug therapy , Alopecia Areata/drug therapy , Child , HumansSubject(s)
Alopecia , Lichen Planus , Alopecia/complications , Fibrosis , Humans , Lichen Planus/complications , Lichen Planus/diagnosis , MaleSubject(s)
Antihypertensive Agents/adverse effects , Hypertrichosis/chemically induced , Minoxidil/adverse effects , Adolescent , Adult , Aged , Alopecia/drug therapy , Antihypertensive Agents/administration & dosage , Female , Hair Removal , Humans , Hypertrichosis/therapy , Male , Middle Aged , Minoxidil/administration & dosage , Prospective Studies , Severity of Illness Index , Young AdultABSTRACT
The objective of our study was to describe the effectiveness and safety of oral dutasteride (OD) for male androgenetic alopecia in real clinical practice. A retrospective, monocentric, and descriptive study was designed. Male patients with androgenetic alopecia that had received OD for at least 12 months were included. Three or less capsules of 0.5 mg per week were considered low doses. Therapeutic response was assessed by comparison of pre- and post-treatment (at month 12) clinical images by three independent dermatologists with expertise in hair disorders, using a four-point scale (worsening, stabilization, mild improvement or marked improvement). In all, 307 patients with a mean age of 35.3 years (range 18-79) were included. Eight patients (2.6%) required the discontinuation of the drug due to decreased libido (n = 4), gynecomastia (n = 2), mood disorder (n = 1) and erectile dysfunction (n = 1). All these AE resolved after stopping the medication. No AE were detected in patients receiving low doses of OD. The effectiveness was evaluated in the subgroup of 42 patients (13.7%) who received OD in monotherapy: 38 patients improved (90%), 10 of them (23.8%) presenting a marked improvement, 4 patients (9.5%) were stable and none patient worsened. In conclusion, OD is an effective treatment for male androgenetic alopecia in real clinical practice, presenting a good safety profile, especially at lower doses.
Subject(s)
5-alpha Reductase Inhibitors/administration & dosage , Alopecia/drug therapy , Dutasteride/administration & dosage , 5-alpha Reductase Inhibitors/adverse effects , Administration, Oral , Adolescent , Adult , Aged , Dutasteride/adverse effects , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
We describe a series of 9 patients with Epstein-Barr virus (EBV)-positive mucocutaneous lymphoproliferative lesions that broadens the concept of EBV-positive mucocutaneous ulcer. We report 5 female and 4 male patients, with an average age of 74 years (range, 55 to 87 y), 2 of whom were HIV-positive. The lesions were located in the oropharynx, skin, and rectal and/or genital mucosa. Histopathologically, 6 cases showed a polymorphic pattern and 3 had a monomorphic and diffuse one, with angiotropism in 4 cases (2 each with the polymorphic and monomorphic patterns). Three of the cases expressed PDL1. In addition to its presence in the neoplastic lymphoid cells, EBV was also detected in adjacent epithelial cells in an oropharyngeal lesion. All cases responded to local therapy or adapted systemic chemotherapy in selected cases. This series extends the spectrum of this disorder to include some HIV-positive cases, patients with multiple lesions confined to a single anatomic area, lesions with an angiocentric pattern, and some cases with monomorphous large-cell cytology. We discuss the differential clinicopathologic diagnosis of this disorder and that of classic EBV large B-cell lymphoma.
Subject(s)
Epstein-Barr Virus Infections/complications , Mucous Membrane/virology , Oral Ulcer/virology , Skin Ulcer/virology , Aged , Aged, 80 and over , Epstein-Barr Virus Infections/pathology , Female , Humans , Male , Middle Aged , Mucous Membrane/pathology , Oral Ulcer/pathology , Skin Ulcer/pathologyABSTRACT
BACKGROUND: Allergic contact dermatitis (ACD) from (meth)acrylates caused by long lasting nail polish (also known as "permanent", "semi-permanent" or "gel nail polish") has been described both in occupational and non-occupational settings. Inexpensive kits for home use have been available for purchase in many stores or through the Internet. OBJECTIVE: To report on several further cases of consumers sensitised to these nail products. METHODS: Patch test results and evaluation of ingredient labelling of products brought in by the patients. RESULTS: Four new cases are presented. Three of the patients reacted to 2-hydroxypropyl methacrylate, 2-hydroxyethyl methacrylate and ethyleneglycol dimethacrylate (EGDMA), and all 4 to 2-hydroxy ethylacrylate. CONCLUSIONS: Acrylates are present in a wide range of products including medical materials. Sensitization from (meth)acrylates caused by a merely aesthetic procedure might significantly impact health by jeopardizing access to several types of medical interventions. Policies should be implemented restricting the use of long-lasting nail polishes to qualified professionals and banning the indiscriminate sale of kits for home use.
